Squarepoint Ops LLC Aldeyra Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.77 - $4.22 $96,315 - $146,733	-34,771 Reduced 47.66%	38,193 $124,000
Q4 2023 Feb 14, 2024	BUY	$1.47 - $6.06 $107,257 - $442,161	72,964 New	72,964 $256,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $386,866 - $665,786	67,048 New	67,048 $665,000
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $42,107 - $84,040	-17,328 Reduced 61.25%	10,964 $44,000
Q1 2022 May 16, 2022	SELL	$3.25 - $5.17 $237,857 - $378,376	-73,187 Reduced 72.12%	28,292 $126,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $197,232 - $542,669	56,352 Added 124.87%	101,479 $406,000
Q3 2021 Nov 15, 2021	BUY	$7.94 - $11.31 $213,252 - $303,763	26,858 Added 147.01%	45,127 $396,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $190,728 - $271,294	18,269 New	18,269 $207,000
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $248,292 - $319,907	-39,349 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.0 - $7.53 $425,364 - $800,747	-106,341 Reduced 72.99%	39,349 $292,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $5.05 $226,908 - $581,669	115,182 Added 377.55%	145,690 $608,000
Q1 2020 May 15, 2020	BUY	$1.62 - $6.4 $49,422 - $195,251	30,508 New	30,508 $75,000
Q4 2019 Feb 14, 2020	SELL	$4.73 - $7.98 $291,817 - $492,326	-61,695 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.41 - $6.12 $274,932 - $381,539	-62,343 Reduced 50.26%	61,695 $325,000
Q2 2019 Aug 14, 2019	BUY	$6.0 - $9.0 $292,404 - $438,606	48,734 Added 64.72%	124,038 $744,000
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $50,686 - $69,925	7,099 Added 10.41%	75,304 $680,000
Q4 2018 Feb 14, 2019	BUY	$7.26 - $13.29 $410,226 - $750,951	56,505 Added 482.95%	68,205 $566,000
Q3 2018 Nov 14, 2018	BUY	$6.8 - $14.35 $79,560 - $167,895	11,700 New	11,700 $161,000
Q4 2017 Feb 14, 2018	SELL	$5.7 - $7.75 $125,799 - $171,042	-22,070 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $86,073 - $238,356	22,070	22,070 $159,000

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$44.4 Million
1.31% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$26.2 Million
14.56% of portfolio
Vanguard Group Inc Valley Forge, PA

3.76M
Shares

$18 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$17.3 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.88M
Shares

$9.01 Million
0.24% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account